Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis

Table 1 Single factor analysis of general data of the three groups of study participants, n (%)

Factors	Case group (n = 60)	Control group (n = 60)	Healthy group (n = 60)	F/χ2/t	P value
Age (yr)	66.78 ± 5.85	61.83 ± 5.36	61.92 ± 5.48	15.563	0.000
Course of disease (yr)	12.99 ± 4.01	8.98 ± 3.83	-	5.601	0.000
BMI (kg/m2)	24.52 ± 2.32	24.73 ± 2.49	23.68 ± 2.05	3.510	0.032
FPG (mmol/L)	8.50 ± 1.50	8.27 ± 1.24	5.77 ± 0.61	99.314	0.000
HbA1c (%)	9.18 ± 1.12	8.76 ± 1.26	5.89 ± 0.70	184.683	0.000
Sex				5.896	0.052
Male	15 (25.00)	25 (41.67)	27 (45.00)
Female	45 (75.00)	35 (58.33)	33 (55.00)
Smoking				2.553	0.279
Yes	9 (15.00)	16 (26.67)	14 (23.33)
No	51 (85.00)	44 (73.33)	46 (76.67)
Drinking				2.182	0.336
Yes	7 (11.67)	11 (18.33)	13 (21.67)
No	53 (88.33)	49 (81.67)	47 (78.33)
Hypertension				23.054	0.000
Yes	15 (25.00)	20 (33.33)	0 (0.00)
No	45 (75.00)	40 (66.67)	60 (100.00)
Coronary heart disease				9.449	0.009
Yes	5 (8.33)	9 (15.00)	0 (0.00)
No	55 (91.67)	51 (85.00)	60 (100.00)

BMI: body mass index; FPG: Fasting plasma glucose.